NOTE TO SCHEME PARTICIPANTS RECORDED IN THE SOUTH AFRICAN REGISTER AND THEIR BROKERS AND CSDPS: DUE TO THE CROSS-BORDER IMPLEMENTATION OF THE SETTLEMENT OF THE SCHEME CONSIDERATION SHARES, TRADING IN THE ENTITLEMENTS TO THE SCHEME CONSIDERATION SHARES WILL ONLY COMMENCE ON THE SCHEME JSE LDT PLUS 2 BUSINESS DAYS (WEDNESDAY, 31 DECEMBER 2025) DESPITE THE LISTING OF SUCH SCHEME CONSIDERATION SHARES TAKING PLACE ON SCHEME JSE LDT PLUS 1 BUSINESS DAY (TUESDAY, 30 DECEMBER 2025).
For the full announcement, please click here.
Salient Dates:
The remaining salient dates and times for the implementation of the Scheme are set out below.
Compliance certificate received from the Takeover Panel on | Thursday, 18 December 2025 |
Scheme Finalisation Date | Thursday, 18 December 2025 |
Scheme Finalisation Date announcement released on SENS by 09:00 SAST and on the ASX by 17:00 AEST on | Thursday, 18 December 2025 |
Application for delisting of Renergen Shares lodged with the JSE and the ASX | Friday, 19 December 2025 |
Public Holiday in South African, Australia and USA | Thursday, 25 December 2025 |
Public Holiday in South African and Australia | Friday, 26 December 2025 |
Last day for Renergen Shareholders to request to reposition securities between the South African Register and the Australian Register to ensure that it is completed before the Scheme JSE LDT | Monday, 29 December 2025 |
Scheme JSE LDT in Renergen Shares on the JSE | Monday, 29 December 2025 |
Trading in Renergen Shares on the JSE to be suspended from commencement of trade on | Tuesday, 30 December 2025 |
Scheme ASX LDT in CDIs on the ASX | Tuesday, 30 December 2025 |
Scheme Consideration Shares listed on the JSE at commencement of trade (09:00 SAST) on (see note 1 below) | Tuesday, 30 December 2025 |
Trading by Scheme Participants recorded in the South African Register in the entitlements to the Scheme Consideration Shares listed on the JSE on 30 December 2025 will only commence at the commencement of trade (09:00 SAST) on (see note 1 below) | Wednesday, 31 December 2025 |
Trading in CDI’s on the ASX to be suspended from commencement of trade on | Wednesday, 31 December 2025 |
Public Holiday in South African, Australia and USA | Thursday, 1 January 2026 |
|
Question |
Answer |
| 1. What do Renergen (REN) shareholders holding shares on the JSE need to do? | Renergen shareholders on the JSE need not do anything. Their Renergen shares on the JSE will be exchanged for ASPI shares on the JSE and will be reflected on their account once the transaction is concluded. |
|
2. Do CDI holders have to open a new CSDP/Broker/CDI/other account in the USA to hold ASPI Nasdaq shares? |
Renergen CDI holders do not need to open an account to receive the ASP Isotopes Inc. (ASPI) common stock (shares) being issued as Scheme Consideration. The ASPI shares will be issued directly to the former Renergen CDI holder on the U.S. share register, recorded in the same name that the CDIs were held. The ASPI shares will be issued in book-entry form (i.e. uncertificated) through the Direct Registration System (DRS), with no action needing to be taken by the former Renergen CDI holder. DRS is U.S. market’s equivalent to holding securities in issuer sponsored form in Australia. A DRS holding statement will be despatched by ASPI’s U.S. Transfer Agent, Equiniti, to the shareholder’s registered address. |
| 3. How do I trade my ASPI shares on Nasdaq? | To trade the ASPI shares on Nasdaq the former CDI holder would need to: (i) have a U.S. brokerage account; or (ii) have access to a U.S. broker via their existing Australian broking relationship; or (iii) alternatively use the DRS sale facility service provided by ASPI’s U.S. Transfer Agent, Equiniti. Details of this service will provided in the letter that will accompany the DRS statement. Should you have any additional queries, please contact your broker. |
| 4. How do CDI holders know if they are Scheme Restricted Foreign Renergen Shareholder or know whether they will be treated as such? | It is determined based the Renergen CDI holder’s registered address. The term Scheme Restricted Foreign Renergen Shareholder is defined in the Circular, with this confirming who it applies to: “Scheme Restricted Foreign Renergen Shareholder a Foreign Renergen Shareholder that is registered in, or who is resident, domiciled or located in, or who is a citizen of, a jurisdiction other than South Africa, the British Virgin Islands, Canada, Australia, the United States, the United Kingdom and the European Union, except to the extent that such Foreign Renergen Shareholder satisfies ASPI, in its sole and absolute discretion, that it can receive the Consideration Shares in terms of the Scheme, without ASPI having to register a prospectus or take any other action to comply with the laws of the jurisdiction in which it is registered, resident, domiciled or located, or of which it is a citizen or ASPI satisfies itself of same independently;” In addition, Renergen announced on 11 July that Renergen CDI holders with a registered address in New Zealand are eligible to receive the ASPI shares. “NOTICE TO NEW ZEALAND FOREIGN RENERGEN SHAREHOLDERS Renergen Shareholders are advised that, in accordance with the provisions of the Circular, ASPI has satisfied itself and has determined, in its sole and absolute discretion, that all Foreign Renergen Shareholders who are registered in, or who are resident, domiciled or located in, or who are citizens of, New Zealand, can receive the Consideration Shares in terms of the Scheme without ASPI having to register a prospectus or take any other action to comply with the laws of New Zealand. Accordingly, Foreign Renergen Shareholders who are registered in, or who are resident, domiciled or located in, or who are citizens of, New Zealand will not be treated as Scheme Restricted Foreign Renergen Shareholders (as defined in the Circular), and will receive Consideration Shares in terms of the Scheme, as set out in the Circular.” |
| 5. What do CDI holders need to do to be able to receive cash payments (from fractional entitlements or proceeds of the sale of Scheme Restricted Foreign Renergen Shareholders’ Consideration Shares)? | The payments will be made in Australian dollars and will be paid to the bank account recorded on the Renergen CDI register at Scheme Consideration Record Date. If a banking instruction is not provided, the CDI holder will be sent an Australian dollar cheque to their registered address.
If the CDI holder’s registered address is in New Zealand, the fractional payment will be made via direct credit only and payment will be withheld until bank account details have been provided. Renergen CDIs can update their bank account details by visiting www.investorcentre.com/au. If the CDI holder has already registered as a member, the CDI holder can log in using their user ID and password. If the holder of CDIs is not a member, they will need their holder identification number/securityholder reference number to register. The new user registration process requires an account verification code to be mailed to the CDI holder’s registered address as an additional layer of security to protect their security holding. The CDI holder should allow sufficient time for delivery of the verification code so that they can update their bank account details before the Scheme Consideration Record Date. |